|
|
 |
SENSEX
|
 |
-464.64
|
-0.65%
|
71561.51
|
|
|
NIFTY
|
 |
-136.20
|
-0.63%
|
21574.60
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
14524.07
|
|
|
Nikkei 225
|
 |
89.13
|
0.27%
|
33377.42
|
|
|
FTSE 100
|
 |
-33.50
|
-0.43%
|
7689.60
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
BSE Code |
500087
|
ISIN Demat |
INE059A01026
|
Book Value (Rs) |
320.58
|
|
NSE Code |
CIPLA
|
Dividend Yield % |
0.67
|
Market Cap (Rs) |
1023890.96
|
|
TTM PE(x) |
34.61
|
TTM EPS(Rs) |
36.65
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
ISINNO
|
INE059A01026
|
Phone
|
022-24826000
|
E-mail
|
contactus@cipla.com |
URL
|
www.cipla.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Y K Hamied
|
Managing Director
|
Umang Vohra
|
Company Secretary
|
Rajendra Chopra
|
Listing
|
BSE,NSE,Luxembourg, MCX
|
|
|
|
|
|
|
|
|
|
|
|